Primary Dermal Melanoma A Distinct Subtype of Melanoma

Archives of Dermatology

Volumn 140, Issue 1, 2004, Pages 99-103

  Swetter, Susan M ^a,b   Ecker, Phillip M ^b   Johnson, Denise L ^b   Harvell, Jeff D ^c,d  

^a Dermatology Service   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d North Georgia Dermatopathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY HMB 45; PROTEIN P75; PROTEIN S 100; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DERMIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; PRIMARY DERMAL MELANOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SKIN METASTASIS; SKIN NODULE; SUBCUTANEOUS FAT; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DERMIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; SKIN NEOPLASMS; SUBCUTANEOUS TISSUE; SURVIVAL RATE;

EID: 0347129967     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.1.99     Document Type: Article

References (19)

1. Bowen GM, Chang AE, Lowe L, Hamilton T, Patel R, Johnson TM. Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol. 2000;136:1397-1399.
2. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19:3635-3648.
3. Iwamoto S, Burrows RC, Agoff SN, Piepkorn M, Bothwell M, Schmidt R. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas. Am J Dermatopathol. 2001;23: 288-294.
4. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol. 1996;23:205-210.
5. Smith K, Germain M, Williams J, Skelton H. CD34-positive cellular blue nevi. J Cutan Pathol. 2001;28:145-150.
6. Smith KJ, Mezebish D, Williams J, Elgart ML, Skelton HG. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol. 1998;2:213-223.
7. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17.
8. Giuliano AE, Moseley HS, Morton DL. Clinical aspects of unknown primary melanoma. Ann Surg. 1980;191:98-104.
9. Schlagenhauff B, Stroebel W, Ellwanger U, et al. Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer. 1997;80:60-65.
10. Das Gupta T, Bowden L, Berg JW. Malignant melanoma of unknown primary origin. Surg Gynecol Obstet. 1963;117:341-345.
11. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83:1664-1678.
12. Laveau F, Picot MC, Dereure O, Guilhou JJ, Guillot B. Metastatic melanoma of unknown primary site. Ann Dermatol Venereol. 2001;128:893-898.
13. Anbari KK, Schuchter LM, Bucky LP, et al. Melanoma of unknown primary site: presentation, treatment, and prognosis-a single institution study. Cancer. 1997; 79:1816-1821.
14. Babb GH, McBride CM. Malignant melanoma: the patient with an unknown site of primary origin. Arch Surg. 1975;110:896-900.
15. Milton GW, Shaw HM, McCarthy WH. Occult primary malignant melanoma: factors influencing survival. Br J Surg. 1977;64:805-808.
16. Granter SR, McKee PH, Calonje E, Mihm MC Jr, Busam K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'. Am J Surg Pathol. 2001;25:316-323.
17. Barnhill RL. Tumors of melanocytes. In: Barnhill R, ed. Textbook of Dermatopathology. New York, NY: McGraw Hill Inc; 1998:581.
18. Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus: case report and literature review. J Am Acad Dermatol. 1988;19:712-722.
19. Connelly J, Smith JL. Malignant blue nevus. Cancer. 1991;67:2653-2657.